Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$6.28 - $15.59 $139,547 - $346,425
-22,221 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $89,126 - $173,826
-6,063 Reduced 21.44%
22,221 $339,000
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $687,584 - $950,342
28,284 New
28,284 $804,000
Q1 2020

May 13, 2020

SELL
$7.64 - $27.5 $247,444 - $890,670
-32,388 Closed
0 $0
Q4 2019

Feb 18, 2020

BUY
$15.02 - $20.57 $486,467 - $666,221
32,388 New
32,388 $522,000
Q3 2019

Nov 14, 2019

SELL
$18.85 - $27.5 $1.01 Million - $1.47 Million
-53,427 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$17.37 - $26.27 $362,998 - $548,990
-20,898 Reduced 28.12%
53,427 $1.26 Million
Q1 2019

May 01, 2019

SELL
$10.65 - $25.75 $771,720 - $1.87 Million
-72,462 Reduced 49.37%
74,325 $1.74 Million
Q4 2018

Feb 01, 2019

BUY
$9.26 - $16.38 $588,250 - $1.04 Million
63,526 Added 76.3%
146,787 $1.62 Million
Q3 2018

Nov 14, 2018

BUY
$7.54 - $18.31 $627,787 - $1.52 Million
83,261 New
83,261 $1.39 Million

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.